Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
MBMG Core
PROJECT SUMMARY/ABSTRACT
The Molecular Biology/Molecular Genetics (MBMG) Core has served the NYNORC obesity research community
for the past 5 cycles of this grant. The MBMG Core provides critical research support for obesity-related clinical
and basic research activities in the area of molecular genetics, bioinformatics, and model organism
characterization. The services are widely used and have increased the productivity of NYNORC investigators,
while curtailing costs and facilitating access to advanced genomics technologies. The primary objective of this
Core is to assist investigators to apply the tools and technologies of molecular genetics and genomics to
elucidate the molecular-genetic basis for the pathogenesis and medical/physiological co-morbidities of obesity.
The Specific Aims of the MBMG Core are: 1) To facilitate the application of molecular genetics to problems of
obesity by providing expert consultation on both study design and applicable molecular biological techniques; 2)
To provide standard laboratory services to young investigators and those without formal labs for studies related
to obesity; 3) To develop and make available new cutting edge research tools and reagents. To these ends, the
MBMG Core offers consultation and services for molecular methods including gene expression, DNA extraction,
genotyping, DNA and RNA sequencing, bacterial phylogenetic characterization by 16s rRNA, RNAscope,
clearing of tissue by SHIELD reagents, mouse transgenics, stem cell derivation and differentiation, and genome
editing with CRISPR Cas9, and analytic tools related to these techniques. Core services are of 3 basic types: (i)
On-site Direct Services, (ii) Consultative-Collaborative services with Institutional Cores, (iii) Consultative-
Referral. To gain access to cutting-edge technologies, avoid duplication and to maximally leverage our
resources, we collaborate extensively with other local Core facilities and laboratories. Core personnel provide
assistance ranging from study design to execution of studies and data interpretation. We emphasize service to
young investigators and P&F grantees. The Core has been active in developing new research tools and reagents
and has played an essential role in establishing iPS cell technology and optogenetics for our community. Our
R&D activities are focused on developing new tools and reagents for brain research and genetic manipulations
in cells and model animals. The MBMG Core has been a nexus for intellectual exchange and collaboration, and
an important training venue for students, fellows and junior faculty. During the past cycle, the Core processed
over >20,000 samples from 39 NORC members supported by 43 grants, in addition to 10 non-members.
These services helped investigators generate 68 new grants and 107 publications.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
01-December-1996
Project End Date
14-March-2025
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$207,281
Direct Costs
$147,276
Indirect Costs
$60,005
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$207,281
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P30DK026687-44 7909
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30DK026687-44 7909
Patents
No Patents information available for 5P30DK026687-44 7909
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30DK026687-44 7909
Clinical Studies
No Clinical Studies information available for 5P30DK026687-44 7909
News and More
Related News Releases
No news release information available for 5P30DK026687-44 7909
History
No Historical information available for 5P30DK026687-44 7909
Similar Projects
No Similar Projects information available for 5P30DK026687-44 7909